Tweetstorm: Abuse of the Orphan Drug Act
posted by Alicia Caramenico
on March 22, 2017
The Government Accountability Office has agreed to investigate potential abuses of the Orphan Drug Act, Kaiser Health News reported today. The Act is an important tool in making sure patients with rare diseases have access to much-needed treatment. But as these medications are increasingly prescribed for common, non-orphan conditions, their high prices generate blockbuster profits for drug companies.
Here are some facts on the matter: